Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+6.46%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$81.2B
AUM Growth
+$4.94B
(+6.5%)
Cap. Flow
-$6.9B
Cap. Flow
% of AUM
-8.49%
Top 10 Holdings %
Top 10 Hldgs %
23.23%
Holding
2,664
New
307
Increased
787
Reduced
648
Closed
292
Top Buys
| 1 |
Exelon
EXC
|
+$404M |
| 2 |
American Electric Power
AEP
|
+$295M |
| 3 |
Johnson & Johnson
JNJ
|
+$241M |
| 4 |
UnitedHealth
UNH
|
+$235M |
| 5 |
Charles Schwab
SCHW
|
+$232M |
Top Sells
| 1 |
Consolidated Edison
ED
|
+$312M |
| 2 |
PNC Financial Services
PNC
|
+$292M |
| 3 |
Dollar General
DG
|
+$283M |
| 4 |
Fiserv
FI
|
+$185M |
| 5 |
Salesforce
CRM
|
+$179M |
Sector Composition
| 1 | Technology | 19.56% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 13.29% |
| 4 | Industrials | 12.02% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Acadia Healthcare
ACHC
$1.94B
| $17K | ﹤0.01% |
223
+201
| +914% | +$15.3K |
|
1902
DocuSign
DOCU
$15.9B
| $17K | ﹤0.01% |
343
-187,987
| -100% | -$9.32M |
|
1903
Home Bancorp
HBCP
$437M
| $17K | ﹤0.01% |
+540
| New | +$17K |
|
1904
Lyell Immunopharma
LYEL
$251M
| $17K | ﹤0.01% |
284
-1,043
| -79% | -$62.4K |
|
1905
Manulife Financial
MFC
$52.4B
| $17K | ﹤0.01% |
921
| – | – |
|
1906
MacroGenics
MGNX
$109M
| $17K | ﹤0.01% |
3,315
-10,147
| -75% | -$52K |
|
1907
PG&E
PCG
$33.5B
| $17K | ﹤0.01% |
+1,014
| New | +$17K |
|
1908
Sunrun
RUN
$3.74B
| $17K | ﹤0.01% |
960
| – | – |
|
1909
Vanguard Total World Stock ETF
VT
$52.3B
| $17K | ﹤0.01% |
180
+24
| +15% | +$2.27K |
|
1910
Ventas
VTR
$31.5B
| $17K | ﹤0.01% |
364
+326
| +858% | +$15.2K |
|
1911
Wayfair
W
$11.3B
| $17K | ﹤0.01% |
+264
| New | +$17K |
|
|
HTLF
1912
DELISTED
Heartland Financial USA, Inc.
HTLF
| $17K | ﹤0.01% |
614
| – | – |
|
1913
Arcellx
ACLX
$4.03B
| $16K | ﹤0.01% |
525
+13
| +3% | +$396 |
|
1914
C3.ai
AI
$2.15B
| $16K | ﹤0.01% |
+453
| New | +$16K |
|
1915
Generation Bio
GBIO
$40.3M
| $16K | ﹤0.01% |
308
+12
| +4% | +$623 |
|
1916
Warrior Met Coal
HCC
$3.08B
| $16K | ﹤0.01% |
+413
| New | +$16K |
|
1917
ImmunityBio
IBRX
$2.43B
| $16K | ﹤0.01% |
+5,899
| New | +$16K |
|
1918
Nathan's Famous
NATH
$437M
| $16K | ﹤0.01% |
213
| – | – |
|
1919
Outfront Media
OUT
$3.12B
| $16K | ﹤0.01% |
+1,081
| New | +$16K |
|
1920
Precigen
PGEN
$1.22B
| $16K | ﹤0.01% |
14,770
+50
| +0.3% | +$54 |
|
1921
Shutterstock
SSTK
$715M
| $16K | ﹤0.01% |
340
-126
| -27% | -$5.93K |
|
1922
Adverum Biotechnologies
ADVM
$69.5M
| $15K | ﹤0.01% |
+1,006
| New | +$15K |
|
1923
Custom Truck One Source
CTOS
$1.29B
| $15K | ﹤0.01% |
2,277
-5,005
| -69% | -$33K |
|
1924
DigitalOcean
DOCN
$3.11B
| $15K | ﹤0.01% |
392
-7,190
| -95% | -$275K |
|
1925
DXP Enterprises
DXPE
$1.79B
| $15K | ﹤0.01% |
418
-2,935
| -88% | -$105K |
|